DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Immunosuppressant are 16

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_0122	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Zika virus	Mex2-81	NA	Immunoflourescence assay	Decrease (50 %)	Approved, Investigational	28099856
DrugRepV_0294	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Middle East respiratory syndrome coronavirus	EMC/2012	NA	Real-time PCR	Increase (0.15 Log10 Copies/GAPDH)	Approved, Investigational	26198719
DrugRepV_0295	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Middle East respiratory syndrome coronavirus	EMC/2012	NA	Immunohistochemical assay	No significant effect	Approved, Investigational	26198719
DrugRepV_0395	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Ebola virus	eGFP-EBOV	NA	Fluorescence-based assay	Decrease (50 %)	Approved, Investigational	26041706
DrugRepV_0464	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Ebola virus	eGFP-EBOV	NA	Fluorescence-based assay	Decrease (50 %)	Approved, Investigational	26041706
DrugRepV_0493	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Ebola virus	EBOV-VLP	NA	Flow cytometry	No significant effect	Approved, Investigational	26041706
DrugRepV_0621	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Lassa virus	GP derived Pseudovirus	NA	Luciferase reporter assay	Decrease (69 %)	Approved, Investigational	23577127
DrugRepV_0640	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Lassa virus	Josiah	NA	Real-time PCR	No significant effect	Approved, Investigational	23577127
DrugRepV_0660	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Marburg virus	GP derived Pseudovirus	NA	Luciferase reporter assay	Decrease (81 %)	Approved, Investigational	23577127
DrugRepV_0684	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Ebola virus	GP derived Pseudovirus	NA	Luciferase reporter assay	Decrease (91 %)	Approved, Investigational	23577127
DrugRepV_0705	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Ebola virus	EBOLA-eGFP	NA	Fluorescence-based assay	No significant effect	Approved, Investigational	23577127
DrugRepV_0771	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Zika virus	MEX_I_7	NA	Fluorescence-based assay	Decrease (99.825 %)	Approved, Investigational	27476412
DrugRepV_2779	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-4.5278588 %)	Approved, Investigational	27742486
DrugRepV_5127	Mycophenolate Mofetil	Immunosuppressant	Organ rejection (immunosuppressants)	Crimean-Congo hemorrhagic fever virus	CCHFV/ZsG	NA	Fluorescence-based assay	Decrease (99 %)	Approved, Investigational	29024765
DrugRepV_6139	Mizoribine	Immunosuppressant	Rheumatoid Arthritis	Dengue virus	New Guinea C		DENV replicon assay	Decrease (50 %)	Investigational	29672522
DrugRepV_8169	Mycophenolic Acid	Immunosuppressant	Organ rejection (immunosuppressants)	Vaccinia virus	NA		NA	Decrease (96.7 %)	Approved, Investigational	32708182